Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Functional profiling in Streptococcus mutans: construction and examination of a genomic collection of gene deletion mutants.

Quivey RG Jr, Grayhack EJ, Faustoferri RC, Hubbard CJ, Baldeck JD, Wolf AS, MacGilvray ME, Rosalen PL, Scott-Anne K, Santiago B, Gopal S, Payne J, Marquis RE.

Mol Oral Microbiol. 2015 Dec;30(6):474-95. doi: 10.1111/omi.12107. Epub 2015 Jun 19.

2.

Alkali production associated with malolactic fermentation by oral streptococci and protection against acid, oxidative, or starvation damage.

Sheng J, Baldeck JD, Nguyen PT, Quivey RG Jr, Marquis RE.

Can J Microbiol. 2010 Jul;56(7):539-47. doi: 10.1139/w10-039.

3.

Targets for hydrogen-peroxide-induced damage to suspension and biofilm cells of Streptococcus mutans.

Baldeck JD, Marquis RE.

Can J Microbiol. 2008 Oct;54(10):868-75. doi: 10.1139/w08-078.

PMID:
18923556
4.

Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.

Sheng J, Nguyen PT, Baldeck JD, Olsson J, Marquis RE.

Arch Oral Biol. 2006 Nov;51(11):1015-23. Epub 2006 Jun 27.

PMID:
16806047
5.

Pimecrolimus: absorption, distribution, metabolism, and excretion in healthy volunteers after a single oral dose and supplementary investigations in vitro.

Zollinger M, Waldmeier F, Hartmann S, Zenke G, Zimmerlin AG, Glaenzel U, Baldeck JP, Schweitzer A, Berthier S, Moenius T, Grassberger MA.

Drug Metab Dispos. 2006 May;34(5):765-74. Epub 2006 Feb 7.

PMID:
16467136
6.

Antimicrobial actions of benzimidazoles against oral streptococci.

Nguyen PT, Baldeck JD, Olsson J, Marquis RE.

Oral Microbiol Immunol. 2005 Apr;20(2):93-100.

PMID:
15720569
7.

Anti-microbial efficacy and mode of action studies on a new zinc/ Triclosan formulation.

Brading MG, Cromwell VJ, Jones NM, Baldeck JD, Marquis RE.

Int Dent J. 2003 Dec;53(6 Suppl 1):363-70. Erratum in: Int Dent J. 2014 Apr;64(2):115.

PMID:
14725380
8.

Physiologic actions of zinc related to inhibition of acid and alkali production by oral streptococci in suspensions and biofilms.

Phan TN, Buckner T, Sheng J, Baldeck JD, Marquis RE.

Oral Microbiol Immunol. 2004 Feb;19(1):31-8.

PMID:
14678472
9.

Characterization of UV-peroxide killing of bacterial spores.

Reidmiller JS, Baldeck JD, Rutherford GC, Marquis RE.

J Food Prot. 2003 Jul;66(7):1233-40.

PMID:
12870758
10.

The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactions.

Fischer V, Johanson L, Heitz F, Tullman R, Graham E, Baldeck JP, Robinson WT.

Drug Metab Dispos. 1999 Mar;27(3):410-6.

PMID:
10064574
11.

Biotransformation of the antiemetic 5-HT3 antagonist tropisetron in liver and kidney slices of human, rat and dog with a comparison to in vivo.

Vickers AE, Fischer V, Connors MS, Biggi WA, Heitz F, Baldeck JP, Brendel K.

Eur J Drug Metab Pharmacokinet. 1996 Jan-Mar;21(1):43-50.

PMID:
8839677
12.

The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.

Fischer V, Vickers AE, Heitz F, Mahadevan S, Baldeck JP, Minery P, Tynes R.

Drug Metab Dispos. 1994 Mar-Apr;22(2):269-74.

PMID:
8013282
13.

Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.

Vickers AE, Fischer V, Connors S, Fisher RL, Baldeck JP, Maurer G, Brendel K.

Drug Metab Dispos. 1992 Nov-Dec;20(6):802-9.

PMID:
1362930
14.

Pharmacokinetics and metabolism of the 5-hydroxytryptamine antagonist tropisetron after single oral doses in humans.

Fischer V, Baldeck JP, Tse FL.

Drug Metab Dispos. 1992 Jul-Aug;20(4):603-7.

PMID:
1356742
15.

Metabolism of the tropine indole-3-carboxylate ICS 205-930 by differentiated rat and human hepatoma cells.

Fischer V, Baldeck JP, Wiebel FJ.

Mol Toxicol. 1987-1988 Fall;1(4):341-50.

PMID:
2855746

Supplemental Content

Loading ...
Support Center